Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-142475
Filing Date
2016-09-22
Accepted
2016-09-22 16:40:31
Documents
2
Period of Report
2016-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4218
2 POA DOCUMENT poa.txt EX-24.4_676444 4185
  Complete submission text file 0001209191-16-142475.txt   9799
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Biller Scott (Reporting) CIK: 0001581956 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 161897964